Albireo Pharma Stock Profit Margin
| ALBODelisted Stock | USD 44.15 0.75 1.67% |
Albireo Pharma fundamentals help investors to digest information that contributes to Albireo Pharma's financial success or failures. It also enables traders to predict the movement of Albireo Stock. The fundamental analysis module provides a way to measure Albireo Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Albireo Pharma stock.
Albireo |
Albireo Pharma Company Profit Margin Analysis
Albireo Pharma's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Albireo Pharma Profit Margin | (2.29) % |
Most of Albireo Pharma's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Albireo Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Albireo Pharma has a Profit Margin of -2.2851%. This is 79.62% lower than that of the Biotechnology sector and 90.08% lower than that of the Health Care industry. The profit margin for all United States stocks is 79.93% higher than that of the company.
Albireo Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Albireo Pharma's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Albireo Pharma could also be used in its relative valuation, which is a method of valuing Albireo Pharma by comparing valuation metrics of similar companies.Albireo Pharma is currently under evaluation in profit margin category among related companies.
Albireo Fundamentals
| Return On Equity | -0.93 | |||
| Return On Asset | -0.25 | |||
| Profit Margin | (2.29) % | |||
| Operating Margin | (2.15) % | |||
| Current Valuation | 259.98 M | |||
| Shares Outstanding | 20.74 M | |||
| Shares Owned By Insiders | 3.60 % | |||
| Shares Owned By Institutions | 96.40 % | |||
| Number Of Shares Shorted | 553.91 K | |||
| Price To Earning | (4.16) X | |||
| Price To Book | 4.30 X | |||
| Price To Sales | 7.35 X | |||
| Revenue | 40.58 M | |||
| Gross Profit | 39.22 M | |||
| EBITDA | (19.82 M) | |||
| Net Income | (34.03 M) | |||
| Cash And Equivalents | 180.97 M | |||
| Cash Per Share | 9.23 X | |||
| Total Debt | 10 M | |||
| Debt To Equity | 0.18 % | |||
| Current Ratio | 4.49 X | |||
| Book Value Per Share | 4.84 X | |||
| Cash Flow From Operations | (107.56 M) | |||
| Short Ratio | 0.86 X | |||
| Earnings Per Share | (6.66) X | |||
| Target Price | 44.0 | |||
| Number Of Employees | 130 | |||
| Beta | 1.04 | |||
| Market Capitalization | 915.89 M | |||
| Total Asset | 302.05 M | |||
| Retained Earnings | (171.75 M) | |||
| Working Capital | 26.76 M | |||
| Current Asset | 28.84 M | |||
| Current Liabilities | 2.07 M | |||
| Z Score | 54.6 | |||
| Net Asset | 302.05 M |
About Albireo Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Albireo Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Albireo Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Albireo Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Albireo Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Albireo Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albireo Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against Albireo Stock
| 0.75 | BA | Boeing Earnings Call This Week | PairCorr |
| 0.59 | APAC | Stonebridge Acquisition Symbol Change | PairCorr |
| 0.45 | TRCA | Twin Ridge Capital | PairCorr |
| 0.45 | CSCO | Cisco Systems Fiscal Quarter End 30th of April 2024 | PairCorr |
| 0.43 | LION | Lionheart III Corp | PairCorr |
The ability to find closely correlated positions to Albireo Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Albireo Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Albireo Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Albireo Pharma to buy it.
The correlation of Albireo Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Albireo Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Albireo Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Albireo Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Albireo Stock
If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |